Skip to main content

TWi T112 135mg Pill - blue & yellow capsule/oblong, 22mm

Pill with imprint TWi T112 135mg is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by TWi Pharmaceuticals, Inc.

Fenofibric acid is used in the treatment of High Cholesterol; Hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TWi T112 135mg

Fenofibric acid delayed-release 135 mg TWi T112 135mg

Fenofibric Acid Delayed-Release

TWi T112 135mg
135 mg
Blue & Yellow
22.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
TWi Pharmaceuticals, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.